89 results

• FDA Effort to Recall Tavneos Challenged by Drug Maker

  August 3, 2026

  Irvin Jackson

  Amgen is asking the FDA to reconsider pulling the drug Tavneos from the market, saying their own data shows the drug works as intended.

• Gardasil Settlement Will Result in $50M Payout by HPV Vaccine Manufacturer

  June 5, 2026

  Irvin Jackson

  A $50 million Gardasil settlement agreement will resolve almost all claims that the HPV vaccine carries significant risk of adverse side effects, ending four years of litigation following reports of neurological injuries.

• Autoimmune Disease Risks Linked to Hormone Therapy Treatment: Study

  October 31, 2025

  Martha Garcia

  A new study suggests that the side effects of hormone replacement therapy could cause a small increase in the risk of autoimmune diseases in women.

• Ocaliva Market Withdrawal To Take Final Effect on Nov. 14

  October 21, 2025

  Irvin Jackson

  The recalled liver disease drug Ocaliva will no longer be available to patients after November 14, following its rejection by the FDA over liver injury risks.

• Appeals Court Finds Hundreds of Gardasil Lawsuits Barred by Vaccine Court Deadline

  September 15, 2025

  Irvin Jackson

  The Fourth Circuit Court of Appeals has denied a request to reinstate about 200 Gardasil lawsuits that were dismissed earlier this year.

• Ocaliva Recall Issued Due to Liver Injury Risks

  September 12, 2025

  Irvin Jackson

  Intercept has announced it is removing the liver disease drug Ocaliva from the market after the FDA determined it does more harm than good.

• Gardasil Vaccine Lawsuit Dismissal Appealed to the U.S. 4th Circuit Court of Appeals

  July 23, 2025

  Irvin Jackson

  Briefings are due late next month in an appeal to the dismissal of hundreds of Gardasil lawsuits linking the HPV vaccine to POTS injuries.

• FDA Puts New Stomach Cancer Restrictions in Place for Keytruda, Opdivo

  June 10, 2025

  Irvin Jackson

  Federal regulators have sent letters to Merck and Bristol-Myers Squibb, announcing new restrictions on the use of Keytruda and Opdivo for the treatment of stomach cancer.

• Xeljanz Side Effects May Cause Weight Gain: Study

  May 22, 2025

  Irvin Jackson

  A new study finds that Xeljanz use can lead to a 5% or more increase in weight in the first three months of use, which could continue throughout the first year.

• Only One Dose of HPV Vaccine Needed To Be Effective, Researchers Find

  May 5, 2025

  Irvin Jackson

  A new study appears to show that just one dose of Gardasil is 97% effective, potentially cutting the dosage in half and decreasing potentially harmful side effects.